<mark id="kgada"><ruby id="kgada"><legend id="kgada"></legend></ruby></mark>

      <kbd id="kgada"></kbd>

    1. <wbr id="kgada"><noscript id="kgada"><output id="kgada"></output></noscript></wbr>
    2. <wbr id="kgada"><noscript id="kgada"><output id="kgada"></output></noscript></wbr> <mark id="kgada"></mark>

      1. <bdo id="kgada"><delect id="kgada"><legend id="kgada"></legend></delect></bdo>
        <i id="kgada"></i>

          Profile Core value Main business Legitimacy Social Responsibility
            Patents Research Direction Technology Strength
          API Intermediates Side chain for Paclitaxel and Docetaxel N-1 stage
          Production management QC Quality System branch factory




          Products Center
        Paclitaxel (Semi-synthetic)
        Paclitaxel (Natural)
        Docetaxel Anhydrous
        Docetaxel Trihydrate
        Irinotecan HCl Trihydrate 99.5%
        Etoposide USP31
        Palonosetron Hydrochloride
          N-1 stage of Paclitaxel and Docetaxel
          Main Intermediates
        10-Deacetylbaccatin III
        Baccatin III
          Side chain for Paclixel semi-Synthetic
        (4S,5R)-3-(N-benzoyl)-2,2-dimethyl-4-phenyloxazolidine-5-carboxylic acid
          Side chain of Docetaxel
        (4S,5R)-3-(N-tert-butoxycarbony)-2,2-dimethyl-4-phenyloxazolidine-5-carboxylic acid
          Side chain for Paclitaxel and Docetaxel
        Ethyl (2R,3S)-3-Phenylisoserine Ester
          About us   more  

        Shanghai Jinhe Bio-Pharmaceutical Co., Ltd. (Abrr. "Jinhe") , founded in March 2002, is a pharmaceutical enterprise dedicated to R & D, manufacturing and marketing anti-cancer APIs and their intermediates. Based on the R&D achievement of Fudan University, we began to undertake the international business of processing Paclitaxel API. After years of effort, we successfully developed Paclitaxel, Docetaxel, Irinotecan, Etoposide etc, from natural extracting anti-cancer products into material source anti-cancer APIs. In recent years, we developed new APIs, such as Cabazitaxel, Palonosetron hydrochloride etc. In 2012, we cooperated with Shanghai Zhongxi Sunve Pharmaceutical Co.,Ltd, (Abrr. "Sunve") became a member of Shanghai Pharmaceuticals Holding Co.,Ltd. (Abrr. "SPH"). Since then, we targeted ourselves as the production base of SPH on oncology products....

          News   more  
          Shanghai Jinhe Bio-Technology Co.,Ltd. was renamed Shanghai Jinhe Bio-Pharmaceutical Co.,Ltd.  
          Warmly celebrate Shanghai Jinbe Bio-Pharmaceutical Co., Ltd new GMP factory officially put into operation. It marked the transition from Chemical plant to the Pharmaceutical factory.  
          Our company's booth on API CHINA & INTERPHEX CHINA 2013, NO.: 3BE56  
          Welcome to our ... booth on CPHI, ICSE & BioPh China 2013, NO.: W1B12  
          Welcome to our ... CPHI Worldwide 2013 (Frankfurt, Germany), NO.: 31E12  
          Welcome to our company's booth on CPHI INDIA 2013, NO.: D16 in Hall 1  
          Welcome to our company’s booth on CPHI & ICSE INDIA 2012, NO.:D16 ...  
          We will participate in CPHI & ICSE China 2012during June 26-28, 2012...  
          Welcome to visit us at our booth: A66 during CPHI Japan 2012.  
          Welcome to visit us at our booth: BK02 during API 67-2011 Nanjing.  
          Contact us
            Shanghai Jinhe Bio-Pharmaceutical Co., Ltd.

        Contact: Jeanne

        Direct: +86- 21-59811408

        Mobile : +86- 13472823779


        URL: http://www.kamcil.com


        Shanghai Jinhe Bio-Pharmaceutical Co.,Ltd. CopyRight(C)2006 All Rights Reserved. Supported by ChemNet ChinaChemNet Toocle Copyright Notice ChemNet
        HOME About us Products R & D Production and QA Contact us CHINESE